Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Lung Disease & Respiratory Health Center

Font Size

Scientists Spot New Clues to a Deadly Lung Disease

Idiopathic pulmonary fibrosis always fatal, but research points to possible cause, potential treatment

WebMD News from HealthDay

By EJ Mundell

HealthDay Reporter

WEDNESDAY, June 11, 2014 (HealthDay News) -- Scientists believe they've found a key biological player in idiopathic pulmonary fibrosis (IPF), a uniformly fatal lung disease that kills thousands of Americans each year.

The finding may be another step forward for patients who have typically had a bleak prognosis. Last month, studies revealed that two new medications might offer some hope for the first effective treatment of IPF.

Without a lung transplant, IPF remains an incurable, progressive disease that causes tissue deep in the lungs to stiffen and scar. Seventy percent of patients die within five years.

According to the Coalition for Pulmonary Fibrosis, more than 128,000 Americans suffer from IPF, with 40,000 dying from the disease each year.

The disease starts with shortness of breath or a dry, hacking cough, but soon robs the person's body of the oxygen needed to move about or properly function, according to the U.S National Institutes of Health. Doctors don't know what causes IPF, although they suspect that smoking, genetics, certain viral infections or acid reflux could play a role in damaging the lungs, the NIH said.

In the new study, researchers found that chronically high levels of an injury-repair protein called chitinase 3-like-1 (CHI3L1) seems linked to an accumulation of scar tissue in the lungs of people with IPF.

"The CHI3L1 is doing exactly what it is supposed to do -- it is designed to shut off cell death and decrease injury," study co-senior author Dr. Jack Elias, dean of medicine and biological sciences at Brown University, explained in a university news release.

According to Elias' team, CHI3L1 is produced in response to injuries to lung tissue. The protein helps shield injured cells from dying, and at the same time it helps spur tissue repair -- fibrosis -- to "patch up" the damage. But this mechanism appears to get out of control, so stiff, fibrotic tissue keeps piling up.

"At the same time [the protein] is decreasing cell death it is driving the fibrosis," Elias said. " You've got this ongoing injury so you've got these ongoing attempts to shut off injury, which stimulate scarring."

Today on WebMD

man coughing
You may not even know you have it.
blood clot
Signs of this potentially fatal complication.
man coughing
When a cold becomes bronchitis.
human lungs
Causes behind painful breathing, fluid buildup.

chest x-ray
Bronchitis Overview
Copd Myth Fact Quiz
Energy Boosting Foods

woman coughing
Lung xray and caduceus